Periodontitis
Drug research and approvals for periodontitis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 185 studies of periodontitis are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 185
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
- Periodontal Health and Treatment Outcomes in Students From Three CountriesNCT07946809 · Not applicable · Esra İlkerli Şençağlı · starts May 6, 2026
- The Effect of Smoking on Salivary and Serum Lipidomic Profiles in Patients With PeriodontitisNCT07942727 · Not reported · Ankara University · starts Nov 11, 2026
- Periodontitis in Patients With OsteoarthritisNCT07935421 · Not reported · University of Zagreb · starts Jan 15, 2025
- Topical Corticosteroid and Wound Healing After Periodontal Flap SurgeryNCT07936812 · Not applicable · Kahramanmaras Sutcu Imam University · starts Jun 1, 2026
- Effects of Different Activation Techniques on Antimicrobial Photodynamic Therapy in Apical PeriodontitisNCT07921277 · Not applicable · Karadeniz Technical University · starts Oct 1, 2026
- Effect of Cryotherapeutic and Nanotherapeutic Sodium Hypochlorite on Post-Operative Endodontic Pain.NCT07923669 · Not applicable · October 6 University · starts Jul 1, 2026
- Probiotics Versus Antibiotics as an Adjuvant to Non-surgical Periodontal Treatment Among Smokers With Stage II, Grade B…NCT07923695 · Not applicable · October 6 University · starts Sep 1, 2024
- Ozone Gel Versus Chlorohexidine Gel as an Adjunct to Non-Surgical Treatment of Stage II Periodontitis Grade B Among…NCT07923708 · Not applicable · October 6 University · starts Sep 1, 2026
- A Closed Surgical Technique vs Modified Papilla Preservation TechniqueNCT07919769 · Not applicable · Aristotle University Of Thessaloniki · starts Oct 1, 2026
Approved 4
- DoxycyclineMatrix metalloproteinase 7 inhibitor
- ChlorhexidineCell membrane inhibitor
- MinocyclineBacterial 70S ribosome inhibitor
- Sodium monofluorophosphate
Phase 3 8
- MetronidazoleDNA inhibitor
- AmoxicillinBacterial penicillin-binding protein inhibitor
- TraferminFibroblast growth factor receptor 2 agonist
- Curcumin
- TriclosanBacterial enoyl-[acyl-carrier-protein] reductase inhibitor
- TetracyclineBacterial 70S ribosome inhibitor
- Sodium fluoride
- Water
Phase 2 12 of 25
- MetforminMitochondrial complex I (NADH dehydrogenase) inhibitor
- AtorvastatinHMG-CoA reductase inhibitor
- Fibrin
- Alendronic acidFarnesyl diphosphate synthase inhibitor
- RosuvastatinHMG-CoA reductase inhibitor
- SimvastatinHMG-CoA reductase inhibitor
- ArticaineSodium channel alpha subunit blocker
- Omega-3-ACID ethyl esters
- Aloe
- FlurbiprofenCyclooxygenase inhibitor
- AspirinCyclooxygenase inhibitor
- ClarithromycinBacterial 70S ribosome inhibitor
Phase 1 or earlier 9
- DiclofenacCyclooxygenase inhibitor
- SargramostimGranulocyte-macrophage colony-stimulating factor receptor agonist
- Olive oil
- Nepidermin
- Lycopene
- Withanolide d
- ValacyclovirHuman herpesvirus 1 DNA polymerase inhibitor
- GlucosamineSupplement
- Lactose,
How its trials ended
1,330 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 114 whose ending is known, 61% met their primary endpoint, 12% missed it and 26% stopped early.
- Completed, result not reported74656%
- Ongoing24518%
- Status unknown22517%
- Met its primary endpoint705%
- Stopped: other or unclear151%
- Missed its primary endpoint141%
- Stopped: enrollment or feasibility71%
- Stopped: lack of efficacy5<1%
- Stopped: funding2<1%
- Stopped: sponsor or business decision1<1%
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA